Editorial
New Lungs for Lung Cancer—Perils and Promises
Ece Cali Daylan, Ramaswamy Govindan
JAMA Published Online: July 8, 2026
doi: 10.1001/jama.2026.11478
Despite the recent advances in systemic therapy, survival for patients with metastatic non–small cell lung cancer (NSCLC) without actionable genomic alterations in the tumor is limited.1 A small subset of patients with NSCLC have lung-only metastatic disease and often die of pr...
阅读全文